These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19027156)

  • 1. Opsonized erythrocyte ghosts for liver-targeted delivery of antisense oligodeoxynucleotides.
    Kim SH; Kim EJ; Hou JH; Kim JM; Choi HG; Shim CK; Oh YK
    Biomaterials; 2009 Feb; 30(5):959-67. PubMed ID: 19027156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liver.
    Robaczewska M; Guerret S; Remy JS; Chemin I; Offensperger WB; Chevallier M; Behr JP; Podhajska AJ; Blum HE; Trepo C; Cova L
    Gene Ther; 2001 Jun; 8(11):874-81. PubMed ID: 11423935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethylenimine-based antisense oligodeoxynucleotides of IL-4 suppress the production of IL-4 in a murine model of airway inflammation.
    Seong JH; Lee KM; Kim ST; Jin SE; Kim CK
    J Gene Med; 2006 Mar; 8(3):314-23. PubMed ID: 16292779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.
    Wu D; Boado RJ; Pardridge WM
    J Pharmacol Exp Ther; 1996 Jan; 276(1):206-11. PubMed ID: 8558431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of antisense oligodeoxynucleotides to folate receptor-overexpressing tumor cells.
    Yang L; Li J; Zhou W; Yuan X; Li S
    J Control Release; 2004 Mar; 95(2):321-31. PubMed ID: 14980780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG-appended beta-(1-->3)-D-glucan schizophyllan to deliver antisense-oligonucleotides with avoiding lysosomal degradation.
    Karinaga R; Koumoto K; Mizu M; Anada T; Shinkai S; Sakurai K
    Biomaterials; 2005 Aug; 26(23):4866-73. PubMed ID: 15763266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart polyion complex micelles for targeted intracellular delivery of PEGylated antisense oligonucleotides containing acid-labile linkages.
    Oishi M; Nagatsugi F; Sasaki S; Nagasaki Y; Kataoka K
    Chembiochem; 2005 Apr; 6(4):718-25. PubMed ID: 15756696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids.
    Fattal E; De Rosa G; Bochot A
    Int J Pharm; 2004 Jun; 277(1-2):25-30. PubMed ID: 15158966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?
    Lavigne C; Yelle J; Sauve G; Thierry AR
    AAPS PharmSci; 2002; 4(2):E9. PubMed ID: 12102618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of oligonucleotides against enzymatic degradation by pegylated and nonpegylated branched polyethyleneimine.
    Remaut K; Lucas B; Raemdonck K; Braeckmans K; Demeester J; De Smedt SC
    Biomacromolecules; 2007 Apr; 8(4):1333-40. PubMed ID: 17358077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyelectrolyte complex micelles composed of c-raf antisense oligodeoxynucleotide-poly(ethylene glycol) conjugate and poly(ethylenimine): effect of systemic administration on tumor growth.
    Jeong JH; Kim SH; Kim SW; Park TG
    Bioconjug Chem; 2005; 16(4):1034-7. PubMed ID: 16029047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo.
    Biessen EA; Vietsch H; Rump ET; Fluiter K; Kuiper J; Bijsterbosch MK; van Berkel TJ
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):783-92. PubMed ID: 10359665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of poly(ethylene imine) molecular weight and pegylation on organ distribution and pharmacokinetics of polyplexes with oligodeoxynucleotides in mice.
    Fischer D; Osburg B; Petersen H; Kissel T; Bickel U
    Drug Metab Dispos; 2004 Sep; 32(9):983-92. PubMed ID: 15319340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved formulations of antisense oligodeoxynucleotides using wrapped liposomes.
    Yamauchi M; Kusano H; Saito E; Iwata T; Nakakura M; Kato Y; Uochi T; Akinaga S; Aoki N
    J Control Release; 2006 Aug; 114(2):268-75. PubMed ID: 16860428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
    Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y
    Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery.
    Gomes dos Santos AL; Bochot A; Doyle A; Tsapis N; Siepmann J; Siepmann F; Schmaler J; Besnard M; Behar-Cohen F; Fattal E
    J Control Release; 2006 May; 112(3):369-81. PubMed ID: 16644054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug delivery of antisense molecules to the brain for treatment of Alzheimer's disease and cerebral AIDS.
    Boado RJ; Tsukamoto H; Pardridge WM
    J Pharm Sci; 1998 Nov; 87(11):1308-15. PubMed ID: 9811482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies.
    Khan A; Benboubetra M; Sayyed PZ; Ng KW; Fox S; Beck G; Benter IF; Akhtar S
    J Drug Target; 2004 Jul; 12(6):393-404. PubMed ID: 15545089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective intracellular delivery of oligonucleotides in order to make sense of antisense.
    Shi F; Hoekstra D
    J Control Release; 2004 Jun; 97(2):189-209. PubMed ID: 15196747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.